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Perspectives
906 Historical perspectives of The American Association for Thoracic Surgery:
Frank C. Spencer
Abe DeAnda, Jr, MD, and Aubrey C. Galloway, MD, New York, NYAClinical Guidelines
909 The role of surgical cytoreduction in the treatment of malignant pleural
mesothelioma: Meeting summary of the International Mesothelioma Interest
Group Congress, September 11-14, 2012, Boston, MassCD
CH
DValerie Rusch, MD, Elizabeth H. Baldini, MD, MPH, Raphael Bueno, MD, Marc De Perrot, MD,
Raja Flores, MD, Seiki Hasegawa, MD, Walter Klepetko, MD, Lee Krug, MD,
Lo€ıc Lang-Lazdunski, MD, PhD, FRCS (Eng), Harvey Pass, MD, Walter Weder, MD, and
David J. Sugarbaker, MD, on behalf of the participants in the 2012 International Mesothelioma
Interest Group Congress, New York, NY; Boston, Mass; Toronto, Ontario, Canada;
Nishinomiya Hyogo, Japan; Vienna, Austria; London, United Kingdom; and Zurich, SwitzerlandCardiothoracic Surgical
Education and Training
(EDU)
911 Introducing transapical aortic valve implantation (part 1): Effect of
a structured training program on clinical outcome in a series of 500 proceduresTXMiralem Pasic, MD, PhD, Axel Unbehaun, MD, Stephan Dreysse, MD, Semih Buz, MD,
Thorsten Drews, MD, Marian Kukucka, MD, Alexander Mladenow, MD,
Giuseppe D’Ancona, MD, PhD, Roland Hetzer, MD, PhD, and Burkhardt Seifert, PhD,
Berlin, Germany, and Zurich, SwitzerlandCumulative knowledge from the field of TAVI was incorporated into a structured training program
and used successfully to introduce transapical TAVI. The overall 30-day mortality for 500
consecutive high-risk patients was 4.6% (95%CI, 3.1%-6.8%) and was 4.0% (95%CI, 2.6%-6.2%)
for patients without cardiogenic shock.919 Introducing transapical aortic valve implantation (part 2): Institutional
structured training program P
MMiralem Pasic, MD, PhD, Axel Unbehaun, MD, Stephan Dreysse, MD, Semih Buz, MD,
Thorsten Drews, MD, Marian Kukucka, MD, Alexander Mladenow, MD, Roland Hetzer, MD, PhD,
and Giuseppe D’Ancona, MD, PhD, Berlin, GermanyET
/B
SOur institutional structured educational and training program combines cumulative knowledge
from the field with institutional and individual background experience. It enables implementation
of a new procedure safely and efficiently into clinical practice with the intention not to increase
morbidity or mortality during the learning curve.)
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912A The Journal of Thoracic an26 Neoplastic severe central airways obstruction, interventional bronchoscopy: A
decision-making analysis(continued on page 14A
d Cardiovascular Surgery c April 2013Venceslau Hespanhol, PhD, Adriana Magalh~aes, MD, and Agostinho Marques, PhD, Porto,
PortugalEight hundred four patients who underwent rigid bronchoscopy under general anesthesia to treat
severe neoplastic central airways obstruction from 1990 to 2009 were studied. Tumor location and
the morphology of the lesions were the main determinants of the intervention success. The pre-
intervention model adds to the clinical evaluation an important contribution to decision-making
process of performing therapeutic interventional bronchoscopy in a critical setting.933 Surgical decortication as the first-line treatment for pleural empyema
Jung Ar Shin, MD, Yoon Soo Chang, MD, PhD, Tae Hoon Kim, MD, PhD, Seok Jin Haam, MD,
Hyung Jung Kim, MD, PhD, Chul Min Ahn, MD, PhD, and Min Kwang Byun, MD, Seoul, KoreaWe analyzed the outcomes of surgical decortication as a first intervention in patients with
nontuberculous or tuberculous empyema compared with simple drainage. Surgical decortication
showed a better treatment success rate compared with simple drainage and was the best predictor of
treatment success.940 Prevention of the second stage of epithelial loss is a potential novel treatment for
bronchiolitis obliterans
Yunge Zhao, MD, PhD, John F. Steidle, BA, Gilbert R. Upchurch, MD, Irving L. Kron, MD, and
Christine L. Lau, MD, Charlottesville, VaLoss of epithelial cells is a critical event that leads to airway fibrosis in a preclinical BO model. We
have shown that injection of recipient epithelial cells inhibited BO development by preventing
epithelial loss. Use of recipient epithelial cells may be a novel treatment for BO in patients after
lung transplantation.948 Quantifying the incidence and impact of postoperative prolonged alveolar air
leak after pulmonary resection
Shuyin Liang, BSc, Jelena Ivanovic, MSc, Sebastien Gilbert, MD, FRCSC,
Donna E. Maziak, MDCM, MSc, FRCSC, FACS, Farid M. Shamji, MBBS, FRCSC,
R. Sudhir Sundaresan, MD, FRCSC, and Andrew J. E. Seely, MD, PhD, FRCSC, Ottawa, Ontario,
CanadaPAAL is a frequent occurrence (18%) after pulmonary resections. Significant predictors include
lobectomy, severe radiologic emphysema, pathologic emphysema, and percentage of predicted
value for forced expiratory volume in 1 second less than 80%. Most cases can be managed
conservatively, but severe cases of PAAL (26% of PAAL cases; 4.8% of all pulmonary resections)
require additional chest drains, bronchoscopy, reoperation, or life support.955 Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval
to recurrence and survival among low-risk patients with malignant pleural
mesothelioma undergoing surgical macroscopic complete resection
David J. Sugarbaker, MD, Ritu R. Gill, MD, Beow Y. Yeap, ScD, Andrea S. Wolf, MD, MPH,
Marcelo C. DaSilva, MD, Elizabeth H. Baldini, MD, MPH, Raphael Bueno, MD, and
William G. Richards, PhD, Boston, MassHyperthermic intraoperative cisplatin pleural chemotherapy extends the interval to recurrence and
overall survival after macroscopic compete resection in a cohort of patients with the characteristics
of low-risk epithelial malignant pleural mesothelioma.)
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914A The Journal of Thoracic an64 Thoracic stent graft sizing for frozen elephant trunk repair in acute type
A dissection(continued on page 16A
d Cardiovascular Surgery c April 2013Andras Hoffman, MD, Anneke L. M. Damberg, MD, Gereon Sch€alte, MD,
Andreas H. Mahnken, MD, PhD, Ayman Raweh, MD, and R€udiger Autschbach, MD, PhD,
Aachen, GermanyIn 32 patients undergoing the frozen elephant trunk procedure for acute type A dissection, the stent
graft of the hybrid prosthesis was sized according to the total aortic area in diameter and down to the
level of vertebrae T10–T12 in length. The midterm results showed low mortality and morbidity.970 Twenty-five-year outcomes after multiple internal thoracic artery bypass
Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A. Daneshmand, MD,
Jeffrey G. Gaca, MD, Carmelo A. Milano, MD, Donald D. Glower, MD, and Peter K. Smith, MD,
Durham, NC, and Nashville, TennThis study examined ultra long-term outcomes after CABG with no thoracic, single thoracic, and
multiple thoracic artery grafting. In risk-adjusted analyses, single internal thoracic artery grafting
improved composite outcome by 21%, andmultiple thoracic grafting improved results by another 9%.
On the basis of these and similar data, multiple internal thoracic artery grafting should be encouraged.976 Successful linking of the Society of Thoracic Surgeons Database to Social
Security data to examine the accuracy of Society of Thoracic Surgeons
mortality data
Jeffrey P. Jacobs, MD, Sean M. O’Brien, PhD, David M. Shahian, MD, Fred H. Edwards, MD,
Vinay Badhwar, MD, Rachel S. Dokholyan, MPH, Juan A. Sanchez, MD, David L. Morales, MD,
Richard L. Prager, MD, Cameron D. Wright, MD, John D. Puskas, MD, James S. Gammie, MD,
Constance K. Haan, MD, MS, Kristopher M. George, MD, Shubin Sheng, PhD, Eric D. Peterson,
MD, CynthiaM. Shewan, PhD, JaneM. Han, MSW, Phillip A. Bongiorno, BA, Courtney Yohe, MPP,
William G. Williams, MD, John E. Mayer, MD, and Frederick L. Grover, MD, St Petersburg, Tampa,
Orlando, and Jacksonville, Fla; Durham, NC; Boston, Mass; Pittsburgh, Pa; Farmington, Conn;
Houston, Tex; Ann Arbor, Mich; Atlanta, Ga; Baltimore, Md; Chicago, Ill; Washington DC;
Toronto, Ontario, Canada; and Aurora, ColoThe STS-ACSDB has been linked to the SSDMF. This STS-SSMMF link reveals that capture of
30-day deaths occurring before discharge is highly accurate in STS-ACSDB, and these in-hospital
deaths represent the vast majority of all 30-day deaths. Capture of the remaining 30-day deaths
occurring after discharge is less complete and needs improvement.984 Effect of atherothrombotic aorta on outcomes of total aortic arch replacement
Kenji Okada, MD, PhD, Atsushi Omura, MD, Hiroya Kano, CE, Takeshi Inoue, MD,
Takanori Oka, MD, Hitoshi Minami, MD, PhD, and Yutaka Okita, MD, PhD, Kobe, JapanThe effect of an atherothrombotic aorta on the short- and long-term outcomes of TAR, including
postoperative neurologic deficits, remains unknown. In the present retrospective study, we
evaluated this relationship and also elucidated the synergistic effect of multiple other risk factors, in
addition to the atherothrombotic aorta, on the neurologic outcomes.992 Complete revascularization is compromised in off-pump coronary artery
bypass grafting
Mark W. Robertson, BSc, Karen J. Buth, MSc, Keir M. Stewart, MD, Jeremy R. Wood, MD,
John A. Sullivan, MD, Gregory M. Hirsch, MD, and Camille L. Hancock Friesen, MD,
Halifax, Nova Scotia, CanadaThe benefits of OPCAB remain controversial, because some studies have shown a decreased
frequency of complete revascularization in patients undergoing the procedure. We compared
off-pump and on-pump patients and found the long-term outcomes were unaffected, despite the
decreased frequency of complete revascularization in the off-pump patients.)
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S916A The Journal of Thoracic an99 Role of the sinuses of Valsalva on the opening of the aortic valve(continued on page 18A
d Cardiovascular Surgery c April 2013Giuseppe Pisani, MS, Raffaele Scaffa, MD, Ornella Ieropoli, PhD, Edoardo M. Dell’Amico, MS,
Daniele Maselli, MD, Umberto Morbiducci, PhD, and Ruggero De Paulis, MD, Turin, Rome, and
Saluggia, ItalyThe present in vitro study has demonstrated that the presence of sinuses of Valsalva reduces the
gradient across the aortic valve through an increase in the effective orifice area independently of
root compliance. In addition to the well-known effect in diastole, the sinuses of Valsalva appear to
play an important role in systole.1004 Comparison of 30-day outcomes of coronary artery bypass grafting surgery
verus hybrid coronary revascularization stratified by SYNTAX and
euroSCORE
Marzia Leacche, MD, John G. Byrne, MD, Natalia S. Solenkova, MD, PhD,
Brendan Reagan, MD, Tahir I. Mohamed, MD, PhD, Joseph L. Fredi, MD, and
David X. Zhao, MD, Nashville, TennIn this study, we report on our experience on hybrid coronary revascularization compared with
routine CABG surgery stratified by complexity of coronary artery disease (SYNTAX score) and
surgical risk profile (euroSCORE).1013 Clinical analysis of concomitant valve replacement and bipolar radiofrequency
ablation in 191 patients
Li Dong, MD, Bo Fu, MD, Xiao Teng, MD, Hong-sheng Yuan, MD, Shu-lin Zhao, MD, and
Li Ren, MD, Chengdu, ChinaThe safety and efficacy of concomitant bipolar radiofrequency ablation and heart valve
replacement with atrial fibrillation were evaluated. Concomitant bipolar radiofrequency ablation
is an effective and safe technique for treating atrial fibrillation in patients undergoing valve
replacement.Congenital Heart
Disease (CHD)
1018 Long-term functional health status and exercise test variables for patients with
pulmonary atresia with intact ventricular septum: A Congenital Heart
Surgeons Society study
Tara Karamlou, MD, MSc, Jeffrey A. Poynter, MD, Henry L. Walters III, MD,
Jonathan Rhodes, MD, Igor Bondarenko, MD, Sara K. Pasquali, MD, Stephanie M. Fuller, MD,
Linda M. Lambert, RN, Eugene H. Blackstone, MD, Marshall L. Jacobs, MD, Kim Duncan, MD,
Christopher A. Caldarone, MD, William G. Williams, MD, and Brian W. McCrindle, MD, MPH,
San Francisco, Calif; Toronto, Ontario, Canada; Boston, Mass; Ann Arbor, Mich; Philadelphia,
Pa; Salt Lake City, Utah; Cleveland, Ohio; and Omaha, NebFor patients with pulmonary atresia with intact ventricular septum, initial tricuspid valve z-score
facilitates prognostication and selection of repair pathway. Biventricular repair is associated with
suboptimal late exercise performance when initial tricuspid valve z-score is smaller. Borderline
patients with smaller initial tricuspid valve z-score may be more optimally managed with
a univentricular-repair or 1.5–ventricle-repair strategy.)
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S118A The Journal of Thoracic an028 Late recovery of atrioventricular conduction after postsurgical chronic
atrioventricular block is not exceptional(continued on page 20A
d Cardiovascular Surgery c April 2013Irene E. van Geldorp, MD, Ward Y. Vanagt, MD, PhD, Guusje Vugts, BSc, Rik Willems, MD, PhD,
Filip Rega, MD, PhD, Marc Gewillig, MD, PhD, and Tammo Delhaas, MD, PhD, Maastricht,
The Netherlands, and Leuven, BelgiumChronic atrioventricular block is an important complication of surgery for congenital heart disease
and is often thought to be permanent. The occurrence and the clinical implications of spontaneous
late recovery of atrioventricular conduction in patients with postsurgical chronic atrioventricular
block (persisting longer than 14 days) are evaluated and discussed.1033 Surgical management of pulmonary artery sling in children
Matthew S. Yong, BMedSci, Yves d’Udekem, MD, PhD, Christian P. Brizard, MD,
Terry Robertson, MBBS, Colin F. Robertson, MBBS, Robert Weintraub, MBBS, and
Igor E. Konstantinov, MD, PhD, Melbourne and Adelaide, AustraliaMortality in children after pulmonary artery sling repair is determined by the need for tracheal
surgery. Mortality can be reduced with the slide tracheoplasty technique and multidisciplinary team
approach. Survival beyond 1 year after surgery offers an excellent prognosis.1040 Pulmonary valve implantation using self-expanding tissue valve without
cardiopulmonary bypass reduces operation time and blood product use
Qiang Chen, MD, Mark Turner, MD, Massimo Caputo, MD, Serban Stoica, MD,
Stefano Marianeschi, MD, and Andrew Parry, DM, Bristol, United Kingdom, and Madrid, SpainThirteen patients with severe pulmonary regurgitation underwent pulmonary valve implantation
(PVI), 6 without and 7 with cardiopulmonary bypass. There were no major complications in either
group and the mean follow-up was 15 months. It was found that PVI without cardiopulmonary
bypass significantly reduced operating time, blood loss, and blood products requirement.1046 An empirically based tool for analyzing morbidity associated with operations
for congenital heart disease
Marshall L. Jacobs, MD, Sean M. O’Brien, PhD, Jeffrey P. Jacobs, MD,
ConstantineMavroudis, MD, Francois Lacour-Gayet, MD, Sara K. Pasquali, MD, Karl Welke, MD,
Christian Pizarro, MD, Felix Tsai, MD, and David R. Clarke, MD, Cleveland, Ohio; Durham, NC;
St Petersburg, Tampa, and Orlando, Fla; New York, NY; Seattle, Wash; Wilmington, Del; Norfolk,
Va; and Aurora, ColoAn empirically derived morbidity metric for congenital heart surgery is presented. Model-based
estimates of each procedure’s average risk of major complications and average postoperative length
of stay were combined into a composite morbidity score. Procedures were assigned scores ranging
from 0.1 to 5.0 and sorted into 5 relatively homogeneous categories.1058 The effect of cardiopulmonary bypass prime volume on the need for blood
transfusion after pediatric cardiac surgery
Marc E. Richmond, MD, MS, Kevin Charette, CCP, Jonathan M. Chen, MD,
Jan M. Quaegebeur, MD, and Emile Bacha, MD, New York, NYIn this single-center review of 2178 pediatric patients undergoing cardiac surgery with
cardiopulmonary bypass, 266 (12%) did not require any erythrocyte transfusion. In multivariable
analysis controlling for RACHS-1 category, surgeon, minimal core body temperature, and
preoperative hemoglobin, indexed prime volume was a modifiable independent predictor of
requirement of blood transfusion.)
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120A The Journal of Thoracic an065 Efficacy of extracorporeal membrane oxygenation as a bridge to lung
transplantation(continued on page 22A
d Cardiovascular Surgery c April 2013Yoshiya Toyoda, MD, PhD, Jay K. Bhama, MD, Norihisa Shigemura, MD,
Diana Zaldonis, MPH, BSN, Joseph Pilewski, MD, Maria Crespo, MD, and
Christian Bermudez, MD, Pittsburgh and Philadelphia, PaAlthough 23% of patients (7/31) placed on ECMO did not undergo transplantation, the graft
survival after lung transplantation for patients on ECMO preoperatively is excellent (2-year
survival, 74%) despite the high incidence of primary graft dysfunction. ECMO is efficacious as
a bridge to lung transplantation with good post–lung transplant outcomes.1072 Surgical outcomes after cardiac surgery in liver transplant recipients
Takeyoshi Ota, MD, PhD, Rodolfo Rocha, MD, Lawrence M. Wei, MD, Yoshiya Toyoda, MD, PhD,
Thomas G. Gleason, MD, and Christian Bermudez, MD, Pittsburgh, PaThis was a single-center retrospective study to assess the outcomes of liver transplant recipients
undergoing cardiac surgery. The surgical outcomes were respectable, and preoperative
encephalopathy and pulmonary hypertension were independent predictors of late mortality. The
cutoff value of 13.5 for the preoperative MELD score might be useful for predicting surgical
mortality in cardiac surgery.Perioperative
Management (PM)
1077 Transfusion outcomes in patients undergoing coronary artery bypass grafting
treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data
analysis
Lawrence T. Goodnough, MD, Peter K. Smith, MD, Jerrold H. Levy, MD, Robert S. Poston, MD,
Mary A. Short, MSN, Govinda J. Weerakkody, PhD, and LeRoy A. LeNarz, MD, Stanford, Calif,
Durham, NC, Atlanta, Ga, Tucson, Ariz, and Indianapolis, IndAntiplatelet therapy with prasugrel compared with clopidogrel in patients who underwent isolated
bypass surgery in TRITON-TIMI 38 was associated with greater 12-hour chest tube drainage and
platelet transfusions but no difference in total blood component transfusions.1083 Predictors of hyperglycemia after cardiac surgery in nondiabetic patients
Rajesh Garg, MD, Anjali Grover, MD, Siobhan McGurk, BS, and James D. Rawn, MD, Boston,
MassThis large retrospective study investigated the association between preoperative patient
characteristics and postoperative hyperglycemia. The study included 3658 nondiabetic patients
undergoing cardiac surgery. On multivariate logistic regression analysis, age, gender, body mass
index, serum creatinine, left ventricular ejection fraction, previous cardiac surgery, and
preoperative cardiogenic shock were independent predictors of postoperative hyperglycemia.1088 Outcomes of axillary artery side graft cannulation for extracorporeal
membrane oxygenation
Themistokles Chamogeorgakis, MD, Brian Lima, MD, Alexis E. Shafii, MD, Dave Nagpal, MD,
Julie A. Pokersnik, CCP, Jose L. Navia, MD, David Mason, MD, and
Gonzalo V. Gonzalez-Stawinski, MD, Cleveland, Ohio, Athens, Greece, and Dallas, TexAccess for initiation of ECMO can be challenging. Side grafting the axillary artery for ECMO
support is a reasonable choice, but hyperfusion syndrome of the limb was a frequent complication.
Lower extremity ischemia and compartment syndrome requiring fasciotomy were more frequent
after femoral arterial cannulation.)
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S122A The Journal of Thoracic an093 Time in the stair-climbing test as a predictor of thoracotomy postoperative
complications(continued on page 24A
d Cardiovascular Surgery c April 2013Alexandre Ricardo Pepe Ambrozin, PhD, Daniele Cristina Cataneo, MD, PhD,
Karine Aparecida Arruda, MA, and Anto^nio Jose Maria Cataneo, MD, PhD,
S~ao Paulo, BrazilCan stair-climbing time be used to predict the risk for postoperative complications? The
stair-climbing test was performed in 98 patients with a recommendation of thoracotomy. Of these,
27 showed postoperative complications. A patient’s risk to present postoperative complications
increases with increased stair-climbing time.Evolving Technology/
Basic Science (ET/BS)
1098 Bioengineered human and allogeneic pulmonary valve conduits chronically
implanted orthotopically in baboons: Hemodynamic performance and
immunologic consequences
Richard A. Hopkins, MD, Arthur A. Bert, MD, Stephen L. Hilbert, PhD, MD,
Rachael W. Quinn, PhD, Kathleen M. Brasky, VMD, William B. Drake, MD, and
Gary K. Lofland, MD, Kansas City, Mo, San Antonio, Tex, and Providence, RIHuman and baboon bioengineered pulmonary valve conduits were successfully implanted in
baboons and compared with clinically relevant reference valves. Bioengineered valves
prepared with decellularization + conditioning showed reduced antigenicity and prolonged
normal valve function. Despite PRA evidence that xeno-antigenicity can persist,
bioengineered human semilunar valve scaffolds can be evaluated chronically in baboons
without immunosuppression.1108 Nebulized nitrite protects rat lung grafts from ischemia reperfusion
injury
Toshihiro Okamoto, MD, PhD, Xiaoying Tang, MS, Allison Janocha, BS,
Caral F. Farver, MD, Mark T. Gladwin, MD, and Kenneth R. McCurry, MD, Cleveland, Ohio, and
Pittsburgh, PaNebulized nitrite has remarkable cytoprotective effects against ischemia–reperfusion injury in
a rat left lung transplantation model. Data from physiologic, immunologic, and molecular
analyses, as well as pharmacokinetic evaluations, were consistent with the cytoprotective effect
of sodium nitrite against lung ischemia–reperfusion injury. This approach may be clinically
useful strategy.1117 Elevated messenger RNA expression and plasma protein levels of osteopontin
and matrix metalloproteinase types 2 and 9 in patients with ascending aortic
aneurysms
Tuija Huusko, MSc, Tuire Salonurmi, PhD, Panu Taskinen, MD, PhD,
Johanna Liinamaa, MD, PhD, Tatu Juvonen, MD, PhD, Paavo P€a€akk€o, MD, PhD,
Markku Savolainen, MD, PhD, and Sakari Kakko, MD, PhD, Oulu, FinlandThere is significantly increased expression of osteopontin, matrix metalloproteinase type 2, and
matrix metalloproteinase type 9 proteins in plasma and mRNA in aortic tissues from the aortic
aneurysm patient groups compared with controls. According to this study, these proteins play a key
role during aneurysm formation.)
Table of Contents (continued)
ED
ITO
RIA
L
TX
ED
U
G
TS
A
CD
CH
D
PM
ET/B
S124A The Journal of Thoracic an124 A new nonocclusive laser-assisted coronary anastomotic connector in a rabbit
model(continued on page 26A
d Cardiovascular Surgery c April 2013DavidStecher,MD,Bart deBoer,MD,CornelisA.F.Tulleken,MD,PhD,GerardPasterkamp,MD,PhD,
Lex A. van Herwerden, MD, PhD, and Marc P. Buijsrogge, MD, PhD, Utrecht, The NetherlandsThe present study evaluated a new ELANA technique-based coronary anastomotic connector in an
acute rabbit model. The connector consistently created safe, reliable, and fast anastomosis
constructions with good acute patency. This easy-to-use and nonocclusive technique has the
potential to facilitate minimally invasive coronary bypass surgery.Cardiothoracic
Imaging
1130 Internal thoracic vein injury presenting as extrapericardial tamponade after
blunt chest trauma
Kyung Hwa Kim, MD, PhD, Jong Bum Choi, MD, PhD, and Min Ho Kim, MD, PhD, Jeonju,
Republic of Korea1131 Papillary fibroelastoma in tricuspid valve: An unusual cause of atypical chest
pain
Kyung Hwa Kim, MD, PhD, and Jong Bum Choi, MD, PhD, Jeonju, Republic of KoreaSurgical Techniques 1132 One-shot aortic anastomosis with an automatic stapling gun
Go Watanabe, MD, PhD, Hiroshi Ohtake, MD, PhD, Kenji Iino, MD, PhD, andShigeyuki Tomita, MD, PhD, Kanazawa, Japan1134 Thoracoscopic carinal resection and reconstruction in a patient with
mucoepidermoid carcinoma
Ryoichi Nakanishi, MD, PhD, Toshihiro Yamashita, MD, Kenji Muranaka, MD, and
Koichi Shinohara, MD, Kitakyushu, Japan1136 Anterior transpericardial approach for postchemotherapy residual
midvisceral mediastinal mass in metastatic germ cell tumors
Marc de Perrot, MD, Donna Eaton, MD, Philippe L. Bedard, MD, and Michael Jewett, MD,
Toronto, Ontario, Canada1139 The OIDE hook: A retractor for video-assisted thoracic surgery
Junichi Shimada, MD, PhD, and Masanori Shimomura, MD, PhD, Kyoto, JapanBrief Research Report 1141 Cardiac pacing: A novel approach to right ventricle failure during pulmonary
thromboendarterectomy
Vinod Havalad, MD, Matthew Bacchetta, MD, Daniel Y. Wang, MD, Santos E. Cabreriza, MBA,
Linda Aponte-Patel, MD, Bin Cheng, PhD, and Henry M. Spotnitz, MD, Park Ridge, Ill, and
New York, NYOnline Only:
Case Reports
e39 Combined heart-liver transplant in a situs-ambiguous patient with failed
Fontan physiology
Prashanth Vallabhajosyula, MD, MS, Caroline Komlo, BS, Tyler J. Wallen, DO, Kim Olthoff, MD,
and Alberto Pochettino, MD, Philadelphia and Hershey, Pa, and Rochester, Minne41 Epicardial cryoablation resulting in precipitous left ventricular dysfunction
Steven M. Lampert, MD, Gregory F. Michaud, MD, Gregory S. Couper, MD, andJochen D. Muehlschlegel, MD, MMSc, Boston, Mass)
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SLetters to the Editor 126A The Journal of Thoracic an144 FloWatch device for adjustable pulmonary artery banding(continued on page 28A
d Cardiovascular Surgery c April 2013Antonio F. Corno, MD, FRCS (Glasgow), FETCS, FACC, Riyadh, Saudi Arabia1144 Pulsatile control of rotary blood pump and cardiac workload
Mamoru Arakawa, MD, Eisuke Tatsumi, MD, PhD, and Takashi Nishimura, MD, PhD, Osaka and
Tokyo, Japan1145 Reply to the Editor
Tohid Pirbodaghi, MSc, Shannon Axiak, DVM, Alberto Weber, PhD, and Stijn Vandenberghe, PhD,
Bern, Switzerland1146 Radial artery or saphenous vein: A graft of second choice in coronary artery
bypass surgery
Tomislav Kopjar, MD, Bojan Biocina, MD, PhD, and Hrvoje Gasparovic, MD, PhD, Zagreb,
Croatia1147 Reply to the Editor
Christopher Cao, MBBS, Con Manganas, MBBS, Michael Byrom, MBBS, and
Tristan D. Yan, MD, PhD, Sydney, Australia1148 Clinical implications related to preoperative detection of stage IA lung
adenocarcinoma
Alessandro Baisi, MD, Matilde De Simone, MD, PhD, and Ugo Cioffi, MD, PhD, Milan, Italy1148 Reply to the Editor
Morihito Okada, MD, PhD, Yasuhiro Tsutani, MD, PhD, and Yoshihiro Miyata, MD, PhD,
Hiroshima, Japan1149 New standard in lung cancer staging? Aword of warning
Jarosław Ku_zd_zał, MD, PhD, Zbigniew Grochowski, MD, PhD, and Janusz Warmus, MD, PhD,
Cracow, Poland1150 Reply to the Editor
Sai Yendamuri, MBBS, and Todd L. Demmy, MD, FACS, Buffalo, NY1151 Is intracavitary thoracoscopic ultrasonography really needed for every
intraparenchymal pulmonary nodule?
Chengwu Liu, MD, Qiang Pu, MD, and Lunxu Liu, MD, PhD, Chengdu, China1151 Reply to the Editor
Moishe Liberman, MD, PhD, Montreal, Quebec, CanadaAnnouncements The American Association for Thoracic Surgery1153 AATS 93rd Annual Meeting1153 2013 AATS Mitral Conclave1154 AATS Awards Applications)
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